{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:51:18Z","timestamp":1790182278793,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114465","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T23:51:21Z","timestamp":1741996281000},"page":"114465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"152","author":[{"given":"Yifan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114465_bb0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/ATVBAHA.119.312802","article-title":"Macrophages in atherosclerosis regression","volume":"40","author":"Barrett","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.114465_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12872-020-01826-1","article-title":"Serum alanine aminotransferase activity and risk factors for cardiovascular disease in a Caucasian population: the Troms\u00f8 study","volume":"21","author":"Bekkelund","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.intimp.2025.114465_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","article-title":"Statin drug interactions and related adverse reactions: an update","volume":"17","author":"Bellosta","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.intimp.2025.114465_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115900","article-title":"Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease","volume":"218","author":"Biagioli","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/ATVBAHA.114.305116","article-title":"Inhibition of ERK1\/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice","volume":"35","author":"Chen","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.114465_bb0030","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3389\/fphar.2019.00850","article-title":"Tanshinone IIA exerts anti-inflammatory and immune-regulating effects on vulnerable atherosclerotic plaque partially via the TLR4\/MyD88\/NF-\u03baB signal pathway","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12974-020-01981-4","article-title":"Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro","volume":"17","author":"Ding","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2025.114465_bb0040","article-title":"Adiponectin inhibits NLRP3 Inflammasome activation in nonalcoholic steatohepatitis via AMPK-JNK\/ErK1\/2-NF\u03baB\/ROS signaling pathways","volume":"7","author":"Dong","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.intimp.2025.114465_bb0045","article-title":"Metabolic dysfunction-associated steatotic liver disease and the heart","author":"Driessen","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114465_bb0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-01299-y","article-title":"Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK\/MAPK in mice","volume":"8","author":"Fang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.114465_bb0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC health promotion series","volume":"72","author":"Ference","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2025.114465_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119703","article-title":"miRNAs through \u03b2-ARR2\/p-ERK1\/2 pathway regulate the VSMC proliferation and migration","volume":"279","author":"Ghasempour","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.114465_bb0065","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1186\/s12889-023-17332-w","article-title":"Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort","volume":"23","author":"Ghavami","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.intimp.2025.114465_bb0070","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/10409238.2021.1925217","article-title":"Cholesterol efflux pathways, inflammation, and atherosclerosis","volume":"56","author":"Groenen","year":"2021","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.intimp.2025.114465_bb0075","first-page":"3333","article-title":"Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity","volume":"16","author":"Guo","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0080","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1177\/0300060519859750","article-title":"Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4","volume":"47","author":"Huang","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.intimp.2025.114465_bb0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2025.114465_bb0090","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2025.114465_bb0095","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/ATVBAHA.120.313584","article-title":"Macrophage biology in cardiovascular diseases","volume":"41","author":"Khoury","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.114465_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.intimp.2025.114465_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106961","article-title":"Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-\u03baB and MAPK pathways and activating the Nrf2 pathway in mice","volume":"88","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0110","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.114465_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109895","article-title":"Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS\/P38\/Nrf2 axis and PI3K\/AKT\/mTOR pathway in macrophages","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114465_bb0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114465_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115501","article-title":"Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2","volume":"167","author":"Ma","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.114465_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejim.2023.11.012","article-title":"Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Mellemkj\u00e6r","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0135","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2025.114465_bb0140","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2174\/0929867325666180320121137","article-title":"Modified and dysfunctional lipoproteins in atherosclerosis: effectors or biomarkers?","volume":"26","author":"Orekhov","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2025.114465_bb0145","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.30223","article-title":"Relationship among fatty liver, specific and multiple-site atherosclerosis, and 10-year Framingham score","volume":"69","author":"Pais","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114465_bb0150","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.2147\/IJN.S168556","article-title":"Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice","volume":"13","author":"Pan","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2025.114465_bb0155","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2310\/JIM.0b013e318217f3a0","article-title":"Recent insights into the relationship between inflammatory liver diseases and atherosclerosis","volume":"59","author":"Purnak","year":"2011","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123761","article-title":"Role of p38 MAPK in atherosclerosis and aortic valve sclerosis","volume":"19","author":"Reustle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114465_bb0165","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.1101909","article-title":"Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis","volume":"306","author":"Ricci","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.intimp.2025.114465_bb0170","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117577","article-title":"Lifestyle factors as determinants of atherosclerotic cardiovascular health","volume":"395","author":"Schmidt-Trucks\u00e4ss","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2025.114465_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.22578","article-title":"Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance","volume":"49","author":"Singh","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114465_bb0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"S\u00f6derberg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2025.114465_bb0190","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3748\/wjg.v17.i33.3785","article-title":"JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease","volume":"17","author":"Tarantino","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2025.114465_bb0195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes","volume":"53","author":"Targher","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.114465_bb0200","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke Statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2025.114465_bb0205","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","article-title":"The multifaceted roles of macrophages in NAFLD pathogenesis","volume":"15","author":"Vonderlin","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2025.114465_bb0210","doi-asserted-by":"crossref","first-page":"1233709","DOI":"10.3389\/fphar.2023.1233709","article-title":"Tanshinone IIA alleviates atherosclerosis in LDLR(\u2212\/\u2212) mice by regulating efferocytosis of macrophages","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2025.114465_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116675","article-title":"Puerarin-Tanshinone IIA suppresses atherosclerosis inflammatory plaque via targeting succinate\/HIF-1\u03b1\/IL-1\u03b2 axis","volume":"317","author":"Xu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0225","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3892\/mmr.2015.4697","article-title":"Inhibition of ERK1\/2 improves lipid balance in rat macrophages via ABCA1\/G1 and CD36","volume":"13","author":"Xue","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2025.114465_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100534","article-title":"Cholesterol trafficking to the ER leads to the activation of CaMKII\/JNK\/NLRP3 and promotes atherosclerosis","volume":"65","author":"Yalcinkaya","year":"2024","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2025.114465_bb0235","article-title":"Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP\/TAZ\/JNK signaling pathway in endothelial cells and pericytes","volume":"1865","author":"Yang","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.intimp.2025.114465_bb0240","first-page":"4225","article-title":"Tanshinone IIA improves diabetes mellitus via the NF-\u03baB-induced AMPK signal pathway","volume":"16","author":"Yuan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.atherosclerosis.2008.12.012","article-title":"Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans","volume":"205","author":"Yun","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2025.114465_bb0250","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1142\/S0192415X20500718","article-title":"Lipophilic extract and Tanshinone IIA derived from Salvia miltiorrhiza attenuate uric acid nephropathy through suppressing oxidative stress-activated MAPK pathways","volume":"48","author":"Zhang","year":"2020","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.intimp.2025.114465_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731769","article-title":"Guanxinkang decoction attenuates the inflammation in atherosclerosis by regulating Efferocytosis and MAPKs signaling pathway in LDLR(\u2212\/\u2212) mice and RAW264.7 cells","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0260","article-title":"Astragaloside IV relieves atherosclerosis and hepatic steatosis via MAPK\/NF-\u03baB signaling pathway in LDLR(\u2212\/\u2212) mice","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2025.114465_bb0265","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221079468","article-title":"Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs\/ NF-\u03baB signaling pathways in LDLR\u2212\/\u2212 mice and RAW264.7 cells","volume":"36","author":"Zhang","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:14:28Z","timestamp":1757913268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":53,"alternative-id":["S1567576925004552"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114465","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114465"}}